Evidence map›Paper›PMID 40299223›Full record

ArticleHealth & justice2025

Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records.

Andrea K Finlay, Ekaterina Pivovarova, Mengfei Yu, Christine Timko, Ingrid A Binswanger, David Smelson, Emmeline Taylor, Alex H S Harris

Abstract read
In one paragraph

Article in Health & justice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea K FinlayVA Palo Alto Health Care System, Menlo Park, USA. Andrea.Finlay@va.gov.
Ekaterina PivovarovaUMass Chan Medical School, Worcester, USA.
Mengfei YuVA Palo Alto Health Care System, Menlo Park, USA.
Christine TimkoVA Palo Alto Health Care System, Menlo Park, USA.
Ingrid A BinswangerKaiser Permanente Colorado, Aurora, USA.
David SmelsonEdith Nourse Rogers Memorial Veterans Hospital, Bedford, USA.
Emmeline TaylorVA Palo Alto Health Care System, Menlo Park, USA.
Alex H S HarrisVA Palo Alto Health Care System, Menlo Park, USA.

Funding

Increasing Referrals to Medications for Opioid Use Disorders from Drug Treatment Courts using Organizational Linkage InterventionK23DA049953 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PIVOVAROVA, EKATERINA · 2020 to 2022
$612k
HSRD VA I01 HX002366HSRD VA I01 HX003265HSRD VA IK6 HX002840HSRD VA IK6 HX003906HSRD VA RCS 00-001HSRD VA RCS 14-232NIDA NIH HHS K23 DA049953U.S. Department of Veterans Affairs IIR 16-239
6 · The paper itself

Abstract

backgroundThe Veterans Health Administration has made strides to improve access to medications for opioid use disorder overall. However, quality improvement methods to assess treatment gaps may not sufficiently detect differences in medication access by intersecting patient factors, which may have multiplicative rather than additive effects. This study aimed to determine whether race/ethnicity and legal involvement interact in receipt of medications for opioid use disorder among Veterans Health Administration patients.

methodsUsing national electronic health record data from Fiscal Years 2021-2022, we examined the receipt of medications for opioid use disorder among veterans diagnosed with opioid use disorder who received healthcare at Veterans Health Administration facilities (n = 65,883). We conducted a mixed effects multivariable logistic regression model to examine an interaction effect of race/ethnicity and legal involvement with receipt of any medications for opioid use disorder, both unadjusted and adjusted for patient and facility characteristics.

resultsIn an adjusted logistic regression model, the interaction effect indicated that non-Hispanic Black veterans with legal involvement had the lowest odds of medications for opioid use disorder receipt compared to non-Hispanic White veterans without legal involvement (adjusted odds ratio = 0.67, 95% confidence interval = 0.59-0.77, p <.0001). Non-Hispanic American Indian/Alaska Native patients without legal involvement (adjusted odds ratio = 0.85, 95% confidence interval = 0.73-0.99, p =.04) also had lower odds of receipt of medications for opioid use disorder compared to non-Hispanic White patients without legal involvement. Non-Hispanic White veterans with legal involvement (adjusted odds ratio = 1.07, 95% confidence interval = 1.01-1.14, p =.03) had higher odds of receipt of medications for opioid use disorder compared to non-Hispanic White patients without legal involvement.

conclusionsVeterans Health Administration quality improvement efforts should monitor interacting racial and legal status factors and understand and address patient, clinical, and regulatory barriers to medications for opioid use disorder among Black veterans with legal involvement.

Indexed as

BuprenorphineMethadoneNaltrexoneOpioid-related disordersUnited States Department of Veterans Affairs

Identifiers

PMID40299223
PMCPMC12042357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.